Skip to content
Home/Companies/Biotech/Antaros Medical
Antaros Medical

Antaros Medical

Biotech·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Antaros Medical?

Antaros Medical is a French Biotech company, currently owned by Lauxera Capital Partners since 2025.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Lauxera Capital Partners
Investor
Lauxera Capital Partners
Lauxera Growth II · 2025 · Growth

Key facts

HQFrance
SectorBiotech
Websiteantarosmedical.com

More from Lauxera Growth II

Other portfolio companies in the same fund.

Bridge to Life
Active
MedTechUS· 2026
GenePlanet
Active
BiotechSlovenia· 2026
Acandis
Acandis
Active
MedTechGermany· 2024

More Lauxera Capital Partners portfolio companies

From the same investor, across funds.

Natural Cycles
Natural Cycles
Active
HealthTechSweden· 2024
Ospi
Ospi
Active
HealthTechFrance· 2024
BioLamina
BioLamina
Active
BiotechSweden· 2023
Caresyntax
Active
HealthTechGermany· 2023
Matrix One
Matrix One
Active
HealthTechGermany· 2023
Reapplix
Reapplix
Active
MedTechDenmark· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Antaros Medical?

Antaros Medical is currently owned by Lauxera Capital Partners, through Lauxera Growth II, since 2025.

When did Lauxera Capital Partners acquire Antaros Medical?

Lauxera Capital Partners acquired Antaros Medical in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue